tetano
Editor, Senior Moderator
Diabet Med
. 2021 Jun 29;e14631.
doi: 10.1111/dme.14631. Online ahead of print.
Acute hyperglycaemic crisis after vaccination against COVID-19: A case series
Amy E Edwards[SUP] 1 [/SUP], Ramu Vathenen[SUP] 1 [/SUP], Sian M Henson[SUP] 2 [/SUP], Sarah Finer[SUP] 1 3 [/SUP], Kirun Gunganah[SUP] 1 [/SUP]
Affiliations
Abstract
Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are the most important component of the global response to the COVID-19 pandemic. Although most adverse reactions observed have been mild, the emergence of more serious vaccine-associated adverse events is being closely monitored.
. 2021 Jun 29;e14631.
doi: 10.1111/dme.14631. Online ahead of print.
Acute hyperglycaemic crisis after vaccination against COVID-19: A case series
Amy E Edwards[SUP] 1 [/SUP], Ramu Vathenen[SUP] 1 [/SUP], Sian M Henson[SUP] 2 [/SUP], Sarah Finer[SUP] 1 3 [/SUP], Kirun Gunganah[SUP] 1 [/SUP]
Affiliations
- PMID: 34185927
- DOI: 10.1111/dme.14631
Abstract
Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are the most important component of the global response to the COVID-19 pandemic. Although most adverse reactions observed have been mild, the emergence of more serious vaccine-associated adverse events is being closely monitored.